Dr. Talal Hilal's Guide To Targeted Therapy For Chronic Lymphocytic Leukemia

Dr. Talal Hilal, a hematologist at Mayo Clinic Arizona in Phoenix, explains how BTK inhibitors are used to treat chronic lymphocytic leukemia (CLL).

Patients facing a chronic lymphocytic leukemia (CLL) diagnosis often encounter complex choices about their next steps in treatment.

Here, Dr. Talal Hilal, a hematologist at Mayo Clinic Arizona in Phoenix, helps outline the key considerations for treating the disease, including how BTK inhibitors have transformed treatment and led to long-lasting disease control for many patients.

Your Digital Guide begins below: 2 Chapters / 4 Video Segments

×

Get SurvivorNet in Your Inbox

Our newsletter – vital information, hope, and healing, delivered weekly.

Never want to see this again? Click here to dismiss this module permanently.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider